Key points are not available for this paper at this time.
Clear cell renal cell carcinoma (ccRCC) is a highly vascular tumor.Among surrogate markers that may reflect the neovasculature burden of ccRCC, prostate specific membrane antigen (PSMA) has emerged as a promising one, by virtue of its ability to be measured either immunohistochemically (IHC) and transcriptionally or on positron emission tomography (PET) imaging.1,2 While the relationship
Vlachostergios et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: